دورية أكاديمية
أعرض في EDS

Clinical Metabolomics Identifies Blood Serum Branched Chain Amino Acids as Potential Predictive Biomarkers for Chronic Graft vs. Host Disease.

التفاصيل البيبلوغرافية
العنوان: Clinical Metabolomics Identifies Blood Serum Branched Chain Amino Acids as Potential Predictive Biomarkers for Chronic Graft vs. Host Disease.
المؤلفون: Alborghetti MR; Department of Cell Biology, University of Brasilia, Brasilia, Brazil., Correa MEP; Hematology and Hemotherapy Center, Instituto Nacional de Ciência e Tecnologia do Sangue, University of Campinas, Hemocentro-Unicamp, Campinas, Brazil., Whangbo J; Harvard Medical School, Dana-Farber Cancer Institute, Boston, MA, United States., Shi X; Beth Israel Deaconess Hospital, Harvard Medical School, Boston, MA, United States., Aricetti JA; Brazilian Bioethanol Science and Technology Laboratory (CTBE)/Brazilian Center for Research in Energy and Materials (CNPEM), Campinas, Brazil., da Silva AA; Hematology and Hemotherapy Center, Instituto Nacional de Ciência e Tecnologia do Sangue, University of Campinas, Hemocentro-Unicamp, Campinas, Brazil., Miranda ECM; Hematology and Hemotherapy Center, Instituto Nacional de Ciência e Tecnologia do Sangue, University of Campinas, Hemocentro-Unicamp, Campinas, Brazil., Sforca ML; Brazilian Biosciences National Laboratory (LNBio), Brazilian Center for Research in Energy and Materials (CNPEM), Campinas, Brazil., Caldana C; Brazilian Bioethanol Science and Technology Laboratory (CTBE)/Brazilian Center for Research in Energy and Materials (CNPEM), Campinas, Brazil., Gerszten RE; Beth Israel Deaconess Hospital, Harvard Medical School, Boston, MA, United States., Ritz J; Harvard Medical School, Dana-Farber Cancer Institute, Boston, MA, United States., Zeri ACM; Brazilian Biosciences National Laboratory (LNBio), Brazilian Center for Research in Energy and Materials (CNPEM), Campinas, Brazil.
المصدر: Frontiers in oncology [Front Oncol] 2019 Mar 18; Vol. 9, pp. 141. Date of Electronic Publication: 2019 Mar 18 (Print Publication: 2019).
نوع المنشور: Journal Article
اللغة: English
بيانات الدورية: Publisher: Frontiers Research Foundation] Country of Publication: Switzerland NLM ID: 101568867 Publication Model: eCollection Cited Medium: Print ISSN: 2234-943X (Print) Linking ISSN: 2234943X NLM ISO Abbreviation: Front Oncol Subsets: PubMed not MEDLINE
أسماء مطبوعة: Original Publication: [Lausanne : Frontiers Research Foundation]
مستخلص: The allogeneic hematopoietic stem cell transplantation procedure-the only curative therapy for many types of hematological cancers-is increasing, and graft vs. host disease (GVHD) is the main cause of morbidity and mortality after transplantation. Currently, GVHD diagnosis is clinically performed. Whereas, biomarker panels have been developed for acute GVHD (aGVHD), there is a lack of information about the chronic form (cGVHD). Using nuclear magnetic resonance (NMR) and gas chromatography coupled to time-of-flight (GC-TOF) mass spectrometry, this study prospectively evaluated the serum metabolome of 18 Brazilian patients who had undergone allogeneic hematopoietic stem cell transplantation (HSCT). We identified and quantified 63 metabolites and performed the metabolomic profile on day -10, day 0, day +10 and day +100, in reference to day of transplantation. Patients did not present aGVHD or cGVHD clinical symptoms at sampling times. From 18 patients analyzed, 6 developed cGVHD. The branched-chain amino acids (BCAAs) leucine and isoleucine were reduced and the sulfur-containing metabolite (cystine) was increased at day +10 and day +100. The area under receiver operating characteristics (ROC) curves was higher than 0.79. BCAA findings were validated by liquid chromatography coupled to tandem mass spectrometry (LC-MS/MS) in 49 North American patients at day +100; however, cystine findings were not statistically significant in this patient set. Our results highlight the importance of multi-temporal and multivariate biomarker panels for predicting and understanding cGVHD.
References: Plant Cell. 2001 Jan;13(1):11-29. (PMID: 11158526)
Nat Rev Drug Discov. 2002 Feb;1(2):153-61. (PMID: 12120097)
Proc Natl Acad Sci U S A. 2004 May 18;101(20):7809-14. (PMID: 15136733)
Nat Rev Microbiol. 2005 May;3(5):431-8. (PMID: 15821725)
J Oral Pathol Med. 2005 Sep;34(8):486-93. (PMID: 16091116)
Biol Blood Marrow Transplant. 2005 Dec;11(12):945-56. (PMID: 16338616)
J Nutr. 2006 Jan;136(1 Suppl):288S-93S. (PMID: 16365100)
Physiology (Bethesda). 2006 Oct;21:362-9. (PMID: 16990457)
PLoS Med. 2007 Jan;4(1):e23. (PMID: 17378698)
Clin Cancer Res. 2007 Oct 15;13(20):6107-14. (PMID: 17947475)
J Chromatogr B Analyt Technol Biomed Life Sci. 2008 Aug 15;871(2):164-73. (PMID: 18502700)
Biol Blood Marrow Transplant. 2009 Jan;15(1 Suppl):33-8. (PMID: 19147075)
Lancet. 2009 May 2;373(9674):1550-61. (PMID: 19282026)
Am J Med. 1991 Sep 30;91(3C):140S-144S. (PMID: 1928206)
Bone Marrow Transplant. 2009 Dec;44(11):729-37. (PMID: 19398965)
BMC Bioinformatics. 2009 Dec 16;10:428. (PMID: 20015393)
Biochemistry. 2010 Feb 16;49(6):1059-66. (PMID: 20070126)
Immunol Allergy Clin North Am. 2010 Feb;30(1):75-101. (PMID: 20113888)
Leuk Res. 2010 Sep;34(9):1158-68. (PMID: 20409584)
J Cell Physiol. 1990 Apr;143(1):94-9. (PMID: 2108175)
Blood. 2011 Apr 28;117(17):4651-7. (PMID: 21355084)
PLoS One. 2011 Feb 16;6(2):e16957. (PMID: 21359215)
Nat Med. 2011 Apr;17(4):448-53. (PMID: 21423183)
Plant J. 2011 Oct;68(2):364-76. (PMID: 21699588)
Blood. 2011 Oct 13;118(15):4242-9. (PMID: 21791424)
Am J Physiol Endocrinol Metab. 2012 Jun 1;302(11):E1329-42. (PMID: 22354780)
Circulation. 2012 May 8;125(18):2222-31. (PMID: 22496159)
Nucleic Acids Res. 2012 Jul;40(Web Server issue):W127-33. (PMID: 22553367)
Blood. 2012 Sep 20;120(12):2529-36. (PMID: 22896003)
Blood. 2013 Jan 24;121(4):585-94. (PMID: 23165480)
Bone Marrow Transplant. 2013 May;48(5):722-8. (PMID: 23165502)
Biol Blood Marrow Transplant. 2013 Jan;19(1 Suppl):S10-4. (PMID: 23290438)
Nat Immunol. 2013 May;14(5):500-8. (PMID: 23525088)
Metabolomics. 2013 Apr;9(2):280-299. (PMID: 23543913)
Bone Marrow Transplant. 2014 Mar;49(3):324-31. (PMID: 23872737)
Bone Marrow Transplant. 2013 Nov;48(12):1525-9. (PMID: 23892328)
Int J Hematol. 2013 Sep;98(3):275-92. (PMID: 23959582)
World J Gastroenterol. 2013 Nov 21;19(43):7620-9. (PMID: 24282351)
Blood. 2014 Jan 30;123(5):786-93. (PMID: 24363401)
PLoS One. 2014 Feb 18;9(2):e88868. (PMID: 24558439)
Metabolites. 2013 Jul 05;3(3):552-74. (PMID: 24958139)
Nat Rev Endocrinol. 2014 Dec;10(12):723-36. (PMID: 25287287)
Biol Blood Marrow Transplant. 2015 Jan;21(1):16-23. (PMID: 25452031)
Metabolomics. 2016;12(1):12. (PMID: 27829829)
J Cell Physiol. 1987 Nov;133(2):330-6. (PMID: 3680392)
فهرسة مساهمة: Keywords: biomarkers; bone marrow transplantation; branched chain amino acids; cancer; graft vs. host disease; mass spectrometry; metabolomics; nuclear magnetic resonance
تواريخ الأحداث: Date Created: 20190406 Latest Revision: 20200930
رمز التحديث: 20221213
مُعرف محوري في PubMed: PMC6436081
DOI: 10.3389/fonc.2019.00141
PMID: 30949447
قاعدة البيانات: MEDLINE
الوصف
تدمد:2234-943X
DOI:10.3389/fonc.2019.00141